Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS

Published:2013-01-31 Issue:3 Volume:2 Page:246-255
ISSN:2048-8726
Container-title:European Heart Journal: Acute Cardiovascular Care
language:en
Short-container-title:European Heart Journal: Acute Cardiovascular Care

Author:

Hess Connie N¹,Schulte Phillip J¹,Newby L Kristin¹,Steg Philippe Gabriel²,Dalby Anthony J³,Schweiger Marc J⁴,Lewis Basil S⁵,Armstrong Paul W⁶,Califf Robert M¹,van de Werf Frans⁷,Harrington Robert A⁸

Affiliation:

1. Duke University Medical Center, Durham, NC, USA

2. INSERM, Paris, France

3. Milpark Hospital, Johannesburg, South Africa

4. Baystate Medical Center, Springfield, MA, USA

5. Lady Davis Carmel Medical Center, Haifa, Israel

6. University of Alberta, Edmonton, Alberta, Canada

7. University of Leuven, Leuven, Belgium

8. Stanford University, Stanford, CA, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2048872612474922

Reference20 articles.

1. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

2. Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention

3. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)

4. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

5. Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction;Cardiovascular Revascularization Medicine;2023-06

2. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

3. Efficacy and Safety of Abbreviated Eptifibatide Treatment in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention;The American Journal of Cardiology;2021-01

4. Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention;Cardiology Research;2018

5. Integrins: Integrating the Biology and Therapy of Cell–cell Interactions;Clinical Therapeutics;2017-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3